Evidence map›Paper›PMID 35060093›Full record

ArticleAdvances in therapy2022

Correction to: Single-Inhaler Triple Therapy and Health-Related Quality of Life in COPD: The IMPACT Study.

Maggie Tabberer, C Elaine Jones, Sally Kilbride, David M G Halpin, David A Lomas, Steven Pascoe, Dave Singh, Robert A Wise, Gerard J Criner, Peter Lange and 5 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Advances in therapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Maggie TabbererGlaxoSmithKline plc, Stockley Park West, Uxbridge, Middlesex, UK. margaret.x.tabberer@gsk.com.
C Elaine JonesGlaxoSmithKline plc, Research Triangle Park, NC, USA.
Sally KilbrideGlaxoSmithKline plc, Stockley Park West, Uxbridge, Middlesex, UK.
David M G HalpinUniversity of Exeter Medical School, College of Medicine and Health, University of Exeter, Exeter, UK.
David A LomasUCL Respiratory, University College London, London, UK.
Steven PascoeGlaxoSmithKline plc, Collegeville, PA, USA.
Dave SinghThe Centre for Respiratory Medicine and Allergy, Institute of Inflammation and Repair, Manchester Academic Health Science Centre, University of Manchester, Manchester University NHS Foundation Trust, Manchester, UK.
Robert A WiseThe Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Gerard J CrinerLewis Katz School of Medicine at Temple University, Philadelphia, PA, USA.
Peter LangeUniversity of Copenhagen, Copenhagen, Denmark.
Mark T DransfieldThe Division of Pulmonary, Allergy, and Critical Care Medicine, Lung Health Center, University of Alabama at Birmingham, Birmingham, AL, USA.
MeiLan K HanUniversity of Michigan, Pulmonary and Critical Care, Ann Arbor, MI, USA.
Fernando J MartinezNew York-Presbyterian Hospital/Weill Cornell Medical Center, New York, NY, USA.
Morrys C KaisermannGlaxoSmithKline plc, Collegeville, PA, USA.
David A LipsonGlaxoSmithKline plc, Collegeville, PA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35060093
PMCPMC9172769

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.